D. Vodak

14.0k citations

26 papers · 12.5k · 3 hit papers · h-index 16

Impact in

Inorganic Chemistry top 0.05%
- Metal-Organic Frameworks: Synthesis and Applications
Electronic, Optical and Magnetic Materials top 0.5%
- Magnetism in coordination complexes

Papers in

Pharmaceutical Science 10
- Drug Solubulity and Delivery Systems 10
- Advanced Drug Delivery Systems 6
Inorganic Chemistry 7
- Metal-Organic Frameworks: Synthesis and Applications 5

Co-authors: Omar M. Yaghi (6 shared papers)Mohamed Eddaoudi (4 shared papers)Jaheon Kim (4 shared papers)M. O’Keeffe (4 shared papers)Nathaniel L. Rosi (2 shared papers)Juergen Eckert (1 shared paper)Andrea Sudik (1 shared paper)Michael M. Morgen (9 shared papers)
Journals: Molecular Pharmaceutics (6 papers)Pharmaceutics (3 papers)Journal of Pharmaceutical Sciences (2 papers)AAPS PharmSciTech (2 papers)Pharmaceutical Research (2 papers)
Partner nations: United States Australia Switzerland

In The Last Decade

D. Vodak

26 papers receiving 12.3k citations

Hit Papers

align trajectories log scale

Hydrogen Storage in Microporous Metal-Organic Frameworks 2003 · 4.2k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2003 Science
2002 Science
2002 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by D. Vodak

Since Specialization

Citations

This map shows the geographic impact of D. Vodak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Vodak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Vodak more than expected).

Fields of papers citing papers by D. Vodak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Vodak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Vodak. The network helps show where D. Vodak may publish in the future.

Co-authors

The 25 scholars most cited alongside D. Vodak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Vodak Line = papers co-authored together D. Vodak links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Systematic Design of Pore Size and Functionality in Isoreticular MOFs and Their Application in Methane Storage Science ·Mohamed Eddaoudi, Jaheon Kim, Nathaniel L. Rosi, D. Vodak, Joseph Wachter, M. O’Keeffe, Omar M. Yaghi Hit paper breakdown →	2002	7190
2	Hydrogen Storage in Microporous Metal-Organic Frameworks Science ·Nathaniel L. Rosi, Juergen Eckert, Mohamed Eddaoudi, D. Vodak, Jaheon Kim, M. O’Keeffe, Omar M. Yaghi Hit paper breakdown →	2003	4246
3	Geometric requirements and examples of important structures in the assembly of square building blocks Proceedings of the National Academy of Sciences ·Mohamed Eddaoudi, Jaheon Kim, D. Vodak, Andrea Sudik, Joseph Wachter, M. O’Keeffe, Omar M. Yaghi Hit paper breakdown →	2002	345
4	Impact of Drug-Rich Colloids of Itraconazole and HPMCAS on Membrane Flux in Vitro and Oral Bioavailability in Rats Molecular Pharmaceutics ·Aaron M. Stewart, Michael Graß, Timothy J. Brodeur, Aaron K. Goodwin, Michael M. Morgen, Dwayne T. Friesen, D. Vodak	2017	106
5	Chemical Communications ·D. Vodak, Matthew Braun, Jaheon Kim, Mohamed Eddaoudi, Omar M. Yaghi	2001	103
6	Development of a Biorelevant, Material-Sparing Membrane Flux Test for Rapid Screening of Bioavailability-Enhancing Drug Product Formulations Molecular Pharmaceutics ·Aaron M. Stewart, Michael Graß, Deanna M. Mudie, Michael M. Morgen, Dwayne T. Friesen, D. Vodak	2017	56
7	Computation of Aromatic C₃N₄ Networks and Synthesis of the Molecular Precursor N(C₃N₃)₃Cl₆ Chemistry - A European Journal ·D. Vodak, Ki‐Bum Kim, Lykourgos Iordanidis, Paul G. Rasmussen, Adam J. Matzger, Omar M. Yaghi	2003	52
8	Transformation of Biopharmaceutical Classification System Class I and III Drugs Into Ionic Liquids and Lipophilic Salts for Enhanced Developability Using Lipid Formulations Journal of Pharmaceutical Sciences ·Hywel D. Williams, Leigh Ford, Shea F. Lim, Sifei Han, John M. Baumann, Hannah Sullivan, D. Vodak, Annabel Igonin, Hassan Benameur, Colin W. Pouton, Peter J. Scammells, Christopher J. H. Porter	2017	48
9	Enhancing the Oral Absorption of Kinase Inhibitors Using Lipophilic Salts and Lipid-Based Formulations Molecular Pharmaceutics ·Hywel D. Williams, Leigh Ford, Sifei Han, Kristian J. Tangso, Shea F. Lim, David M. Shackleford, D. Vodak, Hassan Benameur, Colin W. Pouton, Peter J. Scammells, Christopher J. H. Porter	2018	46
10	A novel architecture for achieving high drug loading in amorphous spray dried dispersion tablets International Journal of Pharmaceutics X ·Deanna M. Mudie, Stephanie S. Buchanan, Aaron M. Stewart, Adam J. Smith, Kimberly B. Shepard, Nishant Biswas, Derrick J. Marshall, Alyssa M. Ekdahl, Amanda M. Pluntze, Christopher D. Craig, Michael M. Morgen, John M. Baumann, D. Vodak	2020	37
11	Novel High-Drug-Loaded Amorphous Dispersion Tablets of Posaconazole; In Vivo and In Vitro Assessment Molecular Pharmaceutics ·Deanna M. Mudie, Aaron M. Stewart, Nishant Biswas, Timothy J. Brodeur, Kimberly B. Shepard, Adam J. Smith, Michael M. Morgen, John M. Baumann, D. Vodak	2020	30
12	Local Treatment of Non-small Cell Lung Cancer with a Spray-Dried Bevacizumab Formulation AAPS PharmSciTech ·Kimberly B. Shepard, D. Vodak, Philip J. Kuehl, David Revelli, Yue Zhou, Amanda M. Pluntze, Molly S. Adam, Julia C. Oddo, Lauren Switala, Jonathan L. Cape, John M. Baumann, Michael Banks	2021	26
13	Synthesis and Characterization of [(η⁶-arene)Ru(R₃P)Cl₂] Complexes Synthesis and Reactivity in Inorganic and Metal-Organic Chemistry ·K.D. Redwine, Heather D. Hansen, Sarah Bowley, J. R. Isbell, Michael Sanchez, D. Vodak, John H. Nelson	2000	22
14	Formulation Development and In Vivo Evaluation of a New Dry Powder Formulation of Albuterol Sulphate in Beagle Dogs Pharmaceutical Research ·Philip J. Kuehl, Edward G. Barrett, Jacob D. McDonald, Karin Rudolph, D. Vodak, Dan E. Dobry, David K. Lyon	2010	19
15	Mechanistic Study of Belinostat Oral Absorption From Spray-Dried Dispersions Journal of Pharmaceutical Sciences ·Aaron M. Stewart, I.C. Yates, Deanna M. Mudie, Perrine Pivette, Aaron K. Goodwin, Alyssa Sarmiento, Marcus Winter, Michael M. Morgen, D. Vodak	2018	16
16	5-Azacytidine inhaled dry powder formulation profoundly improves pharmacokinetics and efficacy for lung cancer therapy through genome reprogramming British Journal of Cancer ·Philip J. Kuehl, Carmen S. Tellez, Marcie J. Grimes, Thomas H. March, Mathewos Tessema, David Revelli, Larry M. Mallis, Wendy W. Dye, Tyler Sniegowski, Aaron Badenoch, Michael Burke, Devon Dubose, D. Vodak, Maria A. Picchi, Steven A. Belinsky	2020	16
17	Biologic Comparison of Inhaled Insulin Formulations: ExuberaTM and Novel Spray-Dried Engineered Particles of Dextran-10 AAPS PharmSciTech ·Philip J. Kuehl, Alan D. Cherrington, Dan E. Dobry, Dale S. Edgerton, Dwayne T. Friesen, C.H. Hobbs, Chet Leach, Brice Murri, Doss W. Neal, David K. Lyon, D. Vodak, Matthew D. Reed	2014	15
18	Impact of process parameters on particle morphology and filament formation in spray dried Eudragit L100 polymer Powder Technology ·Kimberly B. Shepard, Molly S. Adam, Michael M. Morgen, Deanna M. Mudie, Daniel T. Regan, John M. Baumann, D. Vodak	2019	14
19	Solvent-Assisted Secondary Drying of Spray-Dried Polymers Pharmaceutical Research ·Kimberly B. Shepard, April M. Dower, Alyssa M. Ekdahl, Michael M. Morgen, John M. Baumann, D. Vodak	2020	13
20	One-Step Synthesis and Structure of an Oligo(spiro-orthocarbonate) Journal of the American Chemical Society ·D. Vodak, Matthew Braun, Lykourgos Iordanidis, Jacques Plévert, Michael R. Stevens, Larry W. Beck, John C. H. Spence, M. O’Keeffe, Omar M. Yaghi	2002	13

About D. Vodak

D. Vodak is a scholar working on Pharmaceutical Science, Inorganic Chemistry, Pulmonary and Respiratory Medicine, Oncology and Spectroscopy, having authored 26 papers that have together received 12.5k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (10 papers), Advanced Drug Delivery Systems (6 papers), Inhalation and Respiratory Drug Delivery (5 papers), Metal-Organic Frameworks: Synthesis and Applications (5 papers), Analytical Methods in Pharmaceuticals (3 papers), Advanced NMR Techniques and Applications (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Inorganic Chemistry (10.1k citations), Electronic, Optical and Magnetic Materials (3.4k citations), Materials Chemistry (7.8k citations), Process Chemistry and Technology (458 citations) and Physical and Theoretical Chemistry (1.1k citations). D. Vodak has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include Omar M. Yaghi, Mohamed Eddaoudi, Jaheon Kim, M. O’Keeffe, Nathaniel L. Rosi, Juergen Eckert, Andrea Sudik, Michael M. Morgen, Aaron M. Stewart and Dwayne T. Friesen. Their work appears in journals such as Molecular Pharmaceutics, Pharmaceutics, Journal of Pharmaceutical Sciences, AAPS PharmSciTech and Pharmaceutical Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

D. Vodak

Impact in

Papers in i

In The Last Decade

D. Vodak

Hit Papers

Peers

Countries citing papers authored by D. Vodak

Fields of papers citing papers by D. Vodak

All Works

About D. Vodak

Explore authors with similar magnitude of impact

Papers in